Arrowstreet Capital’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-192,527
Closed -$4.12M 2003
2025
Q4
$4.12M Buy
192,527
+23,241
+14% +$476K ﹤0.01% 1195
2025
Q3
$2.84M Sell
169,286
-31,619
-16% -$474K ﹤0.01% 1358
2025
Q2
$2.88M Buy
+200,905
New +$2.75M ﹤0.01% 1341
2024
Q2
Sell
-163,665
Closed -$1.64M 1672
2024
Q1
$1.64M Buy
163,665
+125,149
+325% +$1.16M ﹤0.01% 1189
2023
Q4
$358K Buy
+38,516
New +$398K ﹤0.01% 1268
2023
Q3
Sell
-22,925
Closed -$326K 1348
2023
Q2
$326K Buy
+22,925
New +$322K ﹤0.01% 1111
2021
Q4
Sell
-701,354
Closed -$19.9M 1609
2021
Q3
$19.9M Sell
701,354
-212,106
-23% -$6.46M 0.03% 533
2021
Q2
$27.5M Buy
913,460
+810,929
+791% +$23.9M 0.03% 488
2021
Q1
$2.61M Sell
102,531
-161,629
-61% -$4.14M ﹤0.01% 1459
2020
Q4
$6.48M Buy
+264,160
New +$4.96M 0.01% 1095
2020
Q1
Sell
-454,103
Closed -$12.6M 2005
2019
Q4
$12.6M Buy
454,103
+247,347
+120% +$6.2M 0.03% 537
2019
Q3
$4.68M Buy
+206,756
New +$4.71M 0.01% 726
2019
Q2
Sell
-51,623
Closed -$1.4M 1571
2019
Q1
$1.4M Sell
51,623
-122,483
-70% -$4.11M ﹤0.01% 1216
2018
Q4
$5.75M Buy
+174,106
New +$7M 0.02% 553
2018
Q3
Sell
-44,800
Closed -$1.94M 1182
2018
Q2
$1.94M Buy
+44,800
New +$2.15M ﹤0.01% 695
2014
Q4
Sell
-67,347
Closed -$3.69M 1296
2014
Q3
$3.69M Buy
+67,347
New +$3.82M 0.02% 450

Other funds holding MD

Arrowstreet Capital's MD Position: Q1 2026 in Review

Arrowstreet Capital sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 192,527 shares — an estimated $4.12M sold.

Arrowstreet Capital first reported a position in MD in Q3 2014 and held it in 16 quarters. The position peaked at $27.5M in Q2 2021. 297 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Arrowstreet Capital reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 192,527 Pediatrix Medical shares in Q1 2026, an estimated $4.12M.
  • Arrowstreet Capital first reported a position in Pediatrix Medical in Q3 2014 and held it in 16 quarters.
  • Arrowstreet Capital's Pediatrix Medical position peaked at $27.5M in Q2 2021.
  • 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.